[The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)]. [electronic resource]
Producer: 20110929Description: 793-6 p. digitalISSN:- 1672-173X
- Antineoplastic Agents -- pharmacology
- Benzamides
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Line, Tumor
- Daunorubicin -- pharmacology
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate
- K562 Cells
- Philadelphia Chromosome
- Piperazines -- pharmacology
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- genetics
- Pyrazines -- pharmacology
- Pyrimidines -- pharmacology
No physical items for this record
Publication Type: Comparative Study; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.